224 related articles for article (PubMed ID: 27292651)
1. Cutaneous side effects of doxycycline: a pediatric case series.
Bayhan GI; Akbayram S; Ozaydin Yavuz G; Oner AF
Cutan Ocul Toxicol; 2017 Jun; 36(2):140-144. PubMed ID: 27292651
[TBL] [Abstract][Full Text] [Related]
2. Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis.
Ranjbar M; Keramat F; Mamani M; Kia AR; Khalilian FO; Hashemi SH; Nojomi M
Int J Infect Dis; 2007 Mar; 11(2):152-6. PubMed ID: 16798042
[TBL] [Abstract][Full Text] [Related]
3. Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179].
Karabay O; Sencan I; Kayas D; Sahin I
BMC Infect Dis; 2004 Jun; 4():18. PubMed ID: 15214959
[TBL] [Abstract][Full Text] [Related]
4. Doxycycline-rifampin versus doxycycline-rifampin-gentamicin in treatment of human brucellosis.
Mile B; Valerija K; Krsto G; Ivan V; Ilir D; Nikola L
Trop Doct; 2012 Jan; 42(1):13-7. PubMed ID: 22290107
[TBL] [Abstract][Full Text] [Related]
5. Early clinical response to different therapeutic regimens for human brucellosis.
Malik GM
Am J Trop Med Hyg; 1998 Feb; 58(2):190-1. PubMed ID: 9502602
[TBL] [Abstract][Full Text] [Related]
6. Update on childhood brucellosis.
Roushan MR; Amiri MJ
Recent Pat Antiinfect Drug Discov; 2013 Apr; 8(1):42-6. PubMed ID: 22812616
[TBL] [Abstract][Full Text] [Related]
7. Treatment of brucellosis in a young child with trimethoprim/sulfamethoxazole anaphylaxis.
Teker D; Tanir G; Ozmen S; Teke TA; Keles S; Bostancı I
J Infect Public Health; 2014; 7(6):553-6. PubMed ID: 25182510
[TBL] [Abstract][Full Text] [Related]
8. Comparison of three different combination therapies in the treatment of human brucellosis.
Ersoy Y; Sonmez E; Tevfik MR; But AD
Trop Doct; 2005 Oct; 35(4):210-2. PubMed ID: 16354469
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic susceptibility and treatment of brucellosis.
Al-Tawfiq JA; Memish ZA
Recent Pat Antiinfect Drug Discov; 2013 Apr; 8(1):51-4. PubMed ID: 22812615
[TBL] [Abstract][Full Text] [Related]
10. Pediatric Brucellosis: A Challenging Diagnosis-Case Report.
Shaikh A; Sarfaraz M; Ehsan S
J Prim Care Community Health; 2023; 14():21501319231170497. PubMed ID: 37148217
[TBL] [Abstract][Full Text] [Related]
11. Unusual presentations of pediatric neurobrucellosis.
Budnik I; Fuchs I; Shelef I; Krymko H; Greenberg D
Am J Trop Med Hyg; 2012 Feb; 86(2):258-60. PubMed ID: 22302859
[TBL] [Abstract][Full Text] [Related]
12. Open-label randomized trial of oral trimethoprim-sulfamethoxazole, doxycycline, and chloramphenicol compared with trimethoprim-sulfamethoxazole and doxycycline for maintenance therapy of melioidosis.
Chaowagul W; Chierakul W; Simpson AJ; Short JM; Stepniewska K; Maharjan B; Rajchanuvong A; Busarawong D; Limmathurotsakul D; Cheng AC; Wuthiekanun V; Newton PN; White NJ; Day NP; Peacock SJ
Antimicrob Agents Chemother; 2005 Oct; 49(10):4020-5. PubMed ID: 16189075
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of rifampicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis.
Saltoglu N; Tasova Y; Inal AS; Seki T; Aksu HS
Saudi Med J; 2002 Aug; 23(8):921-4. PubMed ID: 12235463
[TBL] [Abstract][Full Text] [Related]
14. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial.
Hashemi SH; Gachkar L; Keramat F; Mamani M; Hajilooi M; Janbakhsh A; Majzoobi MM; Mahjub H
Int J Infect Dis; 2012 Apr; 16(4):e247-51. PubMed ID: 22296864
[TBL] [Abstract][Full Text] [Related]
15. Ciprofloxacin and rifampicin versus doxycycline and rifampicin in the treatment of brucellosis.
Agalar C; Usubutun S; Turkyilmaz R
Eur J Clin Microbiol Infect Dis; 1999 Aug; 18(8):535-8. PubMed ID: 10517189
[TBL] [Abstract][Full Text] [Related]
16. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas.
Solera J; Rodríguez-Zapata M; Geijo P; Largo J; Paulino J; Sáez L; Martínez-Alfaro E; Sánchez L; Sepulveda MA; Ruiz-Ribó MD
Antimicrob Agents Chemother; 1995 Sep; 39(9):2061-7. PubMed ID: 8540716
[TBL] [Abstract][Full Text] [Related]
17. [A comparative therapeutic and multicenter trial of rifampicin and doxycycline versus streptomycin and doxycycline in human brucellosis].
Solera J; Medrano F; Rodríguez M; Geijo P; Paulino J
Med Clin (Barc); 1991 May; 96(17):649-53. PubMed ID: 1905372
[TBL] [Abstract][Full Text] [Related]
18. Open, randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucellosis.
Montejo JM; Alberola I; Glez-Zarate P; Alvarez A; Alonso J; Canovas A; Aguirre C
Clin Infect Dis; 1993 May; 16(5):671-6. PubMed ID: 8507759
[TBL] [Abstract][Full Text] [Related]
19. Brucellosis in children of Dhofar Region, Oman.
El-Amin EO; George L; Kutty NK; Sharma PP; Choithramani RS; Jhaveri VP; Salil P; Bedair SM
Saudi Med J; 2001 Jul; 22(7):610-5. PubMed ID: 11479644
[TBL] [Abstract][Full Text] [Related]
20. A comparison between doxycycline-rifampin and ciprofloxacin-rifampin regimens in the treatment of acute Brucellosis.
Taghvaee MR; Nozadi MS; Hassani M
Indian J Med Sci; 2011 Oct; 65(10):436-43. PubMed ID: 23511044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
